Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Libby's H*O*P*E*

Libby's H*O*P*E*

Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education). To learn more go to
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma... [Ann Oncol. 2014] - PubMed - NCBI -
Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.... [J Med Chem. 2014] - PubMed - NCBI -
Exploiting the synergy between carboplatin and ABT-737 in the treatment of ovarian carcinomas.-... [PLoS One. 2014] - PubMed - NCBI -
A case of recurrent, bilateral ovarian mature teratoma in a young woman.... [BMC Womens Health. 2014] - PubMed - NCBI -
Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the Secretomes of three-dimensional genetic models of ovarian carcinogenesis.... [Int J Cancer. 2014] - PubMed - NCBI -
A population-based case-control study of urinary bisphenol A concentrations and risk of endometriosis. ... [Hum Reprod. 2014] - PubMed - NCBI -
Management of recurrent epithelial ovarian cancer. [Gland Surg. 2014] - PubMed - NCBI -
Vitamin D receptor polymorphisms and cancer. [Adv Exp Med Biol. 2014] - PubMed - NCBI -
Ovarian Cancer Awareness: A Declining Disease Rate, And Looking Ahead to New Drugs. .... -
Improved Survival of Ovarian Cancer Patients Receiving Treatment Guided by Comprehensive Tumour Profiling. .... - MarketWatch -
AstraZeneca is developing new PARP inhibitor for treatment of ovarian cancer. ...... -
Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?... [Eur J Obstet Gynecol Reprod Biol. 2014] - PubMed - NCBI -
BioNews - Study of Ashkenazi Jewish women suggests gene screening rethink. ..... -
Aethlon Medical and Exosome Sciences Announce the Advancement of a Broad-Spectrum Cancer Detection and Monitoring Platform. ......-
In the oncology platform validation studies, 198 single point serum specimens (taken at the time of cancer diagnosis) were analyzed from patients with Glioblastoma, Metastatic Melanoma, Breast cancer, Ovarian cancer, Colorectal cancer and Pancreatic cancer, plus 20 age-matched, female and male non-cancer controls. In the studies, the ESI platform was consistently able to differentiate individuals afflicted with cancer as compared to non-cancer controls. - Libby's H*O*P*E*
Critical Outcome Technologies and UT MD Anderson Cancer Center Sign Letter of Intent for Phase 1 Study of COTI-2 (Akt/PKB inhibitor) in Gyn Cancers. .... -
What is Hereditary Breast and Ovarian Cancer? ...... - MD Anderson Cancer Center Video -
Robotic single-site pelvic lymphadenectomy. ..... -
Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5β1 integrins and hyaluronic acid. ..... -
BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer. ..... -
Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma. ...... -
Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer. ...... -
A large scale population-based cohort study on the risk of ovarian neoplasm in patients with type 2 diabetes mellitus. ...... -
The role of palliative colorectal stents in gynaecologic malignancy. ...... -
Postoperative readmissions following ileostomy formation among patients with a gynecologic malignancy. ...... -
Overall survival after pelvic exenteration for gynecologic malignancy. .... -
Development and internal validation of a prognostic model to predict recurrence free survival in patients with adult granulosa cell tumors of the ovary. ...... -
A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers. ..... -
The association of serous tubal intraepithelial carcinoma with gynecologic pathologies and its role in pelvic serous cancer. ..... -
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma. ...... -
Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer. ...... -
Other ways to read this feed:Feed readerFacebook